TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Mias Lymfterapi AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
104
|
119
|
81 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
42
|
47
|
17 |
EBITDA |
41
|
47
|
17 |
Total assets |
281
|
235
|
192 |
Current assets |
281
|
235
|
192 |
Current liabilities |
27
|
29
|
19 |
Equity capital |
253
|
205
|
174 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.0%
|
87.2%
|
90.6% |
Turnover per employee |
104
|
119
|
81 |
Profit as a percentage of turnover |
40.4%
|
39.5%
|
21.0% |
Return on assets (ROA) |
14.9%
|
20.0%
|
8.9% |
Current ratio |
1040.7%
|
810.3%
|
1010.5% |
Return on equity (ROE) |
16.6%
|
22.9%
|
9.8% |
Change turnover |
-23
|
41
|
-11 |
Change turnover % |
-18%
|
52%
|
-12% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.